P206 Does adherence to DNase change following initiation of Orkambi for the treatment of cystic fibrosis?

C. McKeown; B. O'Neill; C. Addy; S. Caskey; D.G. Downey

doi:10.1016/s1569-1993(19)30500-4

P206 Does adherence to DNase change following initiation of Orkambi for the treatment of cystic fibrosis?

C. McKeown
, B. O'Neill
, C. Addy
, S. Caskey
, D.G. Downey

Research output: Contribution to journal › Meeting abstract › peer-review

Original language	English
Pages (from-to)	S115-S116
Journal	Journal of Cystic Fibrosis
Volume	18
DOIs	https://doi.org/10.1016/s1569-1993(19)30500-4
Publication status	Published - 27 May 2019

Access to Document

10.1016/s1569-1993(19)30500-4Licence: Unspecified

Cite this

@article{c72885a3859a4f2086f31fd281297ce6,

title = "P206 Does adherence to DNase change following initiation of Orkambi for the treatment of cystic fibrosis?",

author = "C. McKeown and B. O'Neill and C. Addy and S. Caskey and D.G. Downey",

year = "2019",

month = may,

day = "27",

doi = "10.1016/s1569-1993(19)30500-4",

language = "English",

volume = "18",

pages = "S115--S116",

journal = "Journal of Cystic Fibrosis",